Study guide

10.1 Continuation Applications

USPTO Registration Examination Patent Bar

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Overview, Registration & MPEP Structure

1.1 Patent Bar Exam Format & Administration 1.2 Practitioner Qualifications & Eligibility 1.3 MPEP Structure & Effective Search Strategies

2 Chapter 2: Subject Matter Eligibility & Utility (35 U.S.C. § 101)

2.1 Patent-Eligible Subject Matter & Statutory Categories 2.2 Judicial Exceptions & the Alice/Mayo Framework 2.3 Utility Requirements & USPTO Utility Guidelines

3 Chapter 3: Novelty & Prior Art Under the AIA (35 U.S.C. § 102)

3.1 First-Inventor-to-File (FITF) & Effective Filing Dates 3.2 The One-Year Inventor Grace Period & Exceptions 3.3 Prior Art Types & Public Availability Standards

4 Chapter 4: Nonobviousness Analysis (35 U.S.C. § 103)

4.1 The Graham Factors & KSR Obviousness Framework 4.2 Combining Prior Art References & Motivation to Combine 4.3 Overcoming § 103 Rejections & Rule 132 Affidavits

5 Chapter 5: Specification & Disclosure Requirements (35 U.S.C. § 112(a))

5.1 Written Description Requirement 5.2 Enablement Requirement & Wands Factors 5.3 Best Mode Requirement & Current Post-AIA Status

6 Chapter 6: Claim Requirements & Definiteness (35 U.S.C. § 112(b)-(f))

6.1 Definiteness & Claim Precision 6.2 Independent & Dependent Claim Construction 6.3 Special Claim Formats: Means-Plus-Function & Markush Claims

7 Chapter 7: Application Types & Filing Procedures (MPEP Chapter 600)

7.1 Provisional Patent Applications 7.2 Nonprovisional Application Parts & Formalities 7.3 Inventor Oaths, Declarations & Assignments

8 Chapter 8: Duty of Disclosure & Information Disclosure Statements

8.1 Duty of Candor & Good Faith 8.2 Information Disclosure Statements (IDS) Requirements 8.3 Correcting Non-Disclosure & Duty Compliance

9 Chapter 9: Patent Prosecution & Office Action Responses (MPEP Chapter 700)

9.1 Initial Examination & Non-Final Office Actions 9.2 Statutory Deadlines & Extension of Time 9.3 Final Office Actions & Post-Final Practice

10 Chapter 10: Continuing Applications & Copendency

10.1 Continuation Applications 10.2 Divisional Applications 10.3 Continuation-in-Part (CIP) Applications & Priority Allocation

11 Chapter 11: Appeals & Interferences/Derivation (MPEP Chapter 1200 & 2300)

11.1 Ex Parte Appeals to the PTAB 11.2 PTAB Appeal Decisions & Judicial Review 11.3 Derivation Proceedings Under the AIA

12 Chapter 12: Post-Grant Proceedings & Corrections (MPEP Chapters 1400 & 2200)

12.1 Reissue Applications & Certificates of Correction 12.2 Ex Parte Reexamination & Supplemental Examination 12.3 Inter Partes Review (IPR) & Post-Grant Review (PGR)

13 Chapter 13: Patent Term, Maintenance Fees & Ownership

13.1 Patent Term Calculation & Patent Term Adjustment (PTA) 13.2 Maintenance Fees & Expiration 13.3 Inventorship, Ownership & Assignment Recordation 13.4 Patent Term Extension Under 35 U.S.C. § 156

14 Chapter 14: International Patent Practice & PCT (MPEP Chapter 1800)

14.1 The Patent Cooperation Treaty (PCT) Overview 14.2 PCT International Phase & Chapter I / Chapter II 14.3 National Phase Entry Under 35 U.S.C. § 371

15 Chapter 15: Special Patent Categories & Professional Conduct

15.1 Design Patents & Plant Patents 15.2 USPTO Rules of Professional Conduct 15.3 Patent Bar Exam Strategy & Open-Book Navigation Tips

16 Chapter 16: Security, Access, Representation & Filing Mechanics

16.1 Secrecy, Application Access & Foreign Filing Licenses 16.2 Representation, Power of Attorney & Correspondence 16.3 Filing Receipt, Certificates of Transmission & Signatures

17 Chapter 17: Restriction, Publication, Allowance & Office Authority

17.1 Restriction, Election, Rejoinder & Double Patenting 17.2 Publication, Preissuance Submissions & Protests 17.3 Allowance, Issue Fee & Withdrawal from Issue 17.4 Examiner Interviews, Petitions & Office Authority

18 Chapter 18: Biotechnology Disclosure & Patent Prosecution Highway

18.1 Biological Deposits & Sequence Listings 18.2 Global/IP5 Patent Prosecution Highway

19 Chapter 19: AIA Trial Practice Under the Consolidated Guide

19.1 AIA Trial Petitions, Preliminary Response & Institution 19.2 AIA Trial Discovery, Motions, Hearing & Final Decision

10.1 Continuation Applications

Key Takeaways Explain This Topic AI

A continuation application is a second application for the same invention disclosed in a prior-filed nonprovisional parent application, filed while the parent is still pending, without adding any new matter.

Under 35 U.S.C. § 120 and 37 C.F.R. § 1.78, claiming benefit requires strict copendency, at least one common inventor, a specific reference in the ADS, and full written description support under 35 U.S.C. § 112(a).

Copendency requires filing while the parent remains pending; issue-date filing is recognized, while abandonment timing must be analyzed from the event that actually terminated the parent.

Continuations are strategically deployed to secure broader claim coverage, pursue dependent claims carved out of allowed parent claims, address commercial competitor products disclosed in the specification, and preserve prosecution rights under RCE or Appeal constraints.

All claims in a proper continuation application inherit the effective filing date of the parent nonprovisional application for prior art rejection purposes under 35 U.S.C. § 102 and § 103.

Last updated: August 2026

10.1 Continuation Applications

A continuation application is a subsequent patent application filed by an applicant for an invention disclosed in a prior-filed, copending nonprovisional application (commonly referred to as the "parent" application). Governed primarily by 35 U.S.C. § 120 , 37 C.F.R. § 1.78 , and MPEP § 201.06 , a continuation application allows an applicant to pursue additional or modified claims based on the identical specification of the parent application without introducing any "new matter."

When properly established, claims in a continuation application are entitled to the benefit of the parent application's earlier effective filing date. This priority benefit immunizes the continuation claims against prior art that was published, disclosed, or patented after the parent's filing date.

Four Statutory Requirements under 35 U.S.C. § 120

To successfully claim the benefit of an earlier nonprovisional application's filing date under 35 U.S.C. § 120, four strict statutory conditions must be satisfied:

Copendency Requirement : The continuation application must be filed while the prior parent application is still pending (before the parent issues as a patent or becomes abandoned).

Written Description & Enablement Support (35 U.S.C. § 112(a)) : The disclosure of the prior parent application must fully support the claims of the continuation application under the written description, enablement, and best mode requirements of 35 U.S.C. § 112(a).

Common Inventorship : The continuation application and the prior parent application must share at least one common inventor (at least one inventor named in the continuation must have been an inventor in the parent).

Specific Reference in the Application Data Sheet (ADS) : The continuation must contain a specific reference to the prior parent application, specifying its application number (or international application number) and its parent-child relationship, submitted in a compliant Application Data Sheet (ADS) within the prescribed timeframes of 37 C.F.R. § 1.78.

Requirement Statutory Standard Exam Focus & Pitfalls

Copendency Filed before or on the date of issue/abandonment Filing one day after patent grant breaks priority forever.

Disclosure Support 35 U.S.C. § 112(a) compliance No "new matter" may be added; specification must match parent.

Inventorship At least one common inventor Complete identity of all inventors is not required.

Reference ADS filing per 37 C.F.R. § 1.78 Mentioning parent in the specification text alone is insufficient for post-AIA applications.

Strict Copendency Standard (MPEP § 211.01(b))

Copendency is a non-negotiable jurisdictional threshold. Under MPEP § 211.01(b) , an application is copending with a prior application if it is filed:

Before the grant or abandonment of the prior application, or

On the same day that the prior application issues as a patent or becomes abandoned.

If a continuation application is filed after the issuance or abandonment of the parent application (even by a single day), copendency is lost. Once copendency is broken, the applicant cannot claim priority under 35 U.S.C. § 120 to that parent application unless the parent application's abandonment is successfully revived under 37 C.F.R. § 1.137 or the issuance issue date is adjusted through an extraordinary petition.

Case Example: Same-Day Filing Rule

If Parent Application A issues as U.S. Patent No. 11,000,000 on Tuesday, May 5, 2026, a continuation Application B filed on Tuesday, May 5, 2026, is legally copending. However, if Application B is filed on Wednesday, May 6, 2026, copendency is destroyed, and Application B cannot claim the benefit of Application A's filing date under 35 U.S.C. § 120.

Inventorship Overlap Rules

Under the Leahy-Smith America Invents Act (AIA) and 35 U.S.C. § 120, the continuation application does not need to name the exact same inventive entity as the parent application. It only requires at least one common inventor .

Adding Inventors : If a continuation application claims an aspect of the parent disclosure that was co-invented by a researcher not named in the parent's narrower claims, that researcher may be named in the continuation.

Deleting Inventors : If claims drawn to a specific co-inventor's contribution are omitted from the continuation, that co-inventor may be excluded from the continuation application's inventorship roster.

No New Matter Prohibition (35 U.S.C. § 132)

By definition, a continuation application must incorporate the exact written description and drawings of the parent application without introducing new matter under 35 U.S.C. § 132. While the claims of the continuation application may be broader, narrower, or directed to different combinations than the parent claims, every limitation recited in the continuation claims must find clear antecedent written description support under 35 U.S.C. § 112(a) within the original parent disclosure.

If an applicant attempts to add new technical disclosure or add claims requiring subject matter not present in the parent specification, the examiner will reject the unsupported claim under 35 U.S.C. § 112(a) and deny the earlier benefit for that claim. Section 132 is used to object when new matter is inserted into the specification, abstract, or drawings. In such cases, the proper vehicle would be a Continuation-in-Part (CIP) application, not a continuation.

Strategic Uses of Continuation Applications

Patent practitioners utilize continuation applications for several critical commercial and procedural objectives:

Securing Immediate Protection while Pursuing Broader Claims : An applicant may allow narrow, allowed claims in the parent application to issue as a patent to obtain early enforcement rights, while simultaneously filing a continuation to pursue broader independent claims.

Responding to Commercial Competitors : If a competitor introduces a competing product after the parent filing date, the applicant can file continuation claims specifically tailored to encompass the competitor's design, provided the competitor's design elements were fully disclosed in the original parent specification.

Preserving Prosecution Rights : When faced with a Final Rejection in a parent application where time is running out to file a Request for Continued Examination (RCE) or Notice of Appeal, an applicant can file a continuation application to maintain an active prosecution line.

Loading diagram... Continuation Application Filing Timeline & 35 U.S.C. § 120 Priority Workflow